Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ALT News Alteon To Seek Cardiovascular Indication For Alagebrium
DJ Alteon Inc Oper Chief Resigns >ALT
02/01/2006
Dow Jones News Services
(Copyright © 2006 Dow Jones & Company, Inc.)
(MORE TO FOLLOW) Dow Jones Newswires
02-01-06 0801ET
Copyright (c) 2006 Dow Jones & Company, Inc.
*DJ
(MORE TO FOLLOW) Dow Jones Newswires
02-01-06 0806ET
Copyright (c) 2006 Dow Jones & Company, Inc.
*DJ Alteon Withdraws Erectile Dysfunction IND For Alagebrium
(MORE TO FOLLOW) Dow Jones Newswires
02-01-06 0807ET
Copyright (c) 2006 Dow Jones & Company, Inc.
*DJ Alteon Sees 'Progress' On Review Of Co Options >ALT
(MORE TO FOLLOW) Dow Jones Newswires
hear it is BKMP NEWS Star Choice Brings a Heavyweight Champion to its Channel Line-Up with the Addition of THE FIGHT NETWORK
Business Wire - February 01, 2006 08:00
CALGARY, Alberta, Feb 01, 2006 (BUSINESS WIRE) -- Shaw Communications Inc. (TSX:SJR.NV.B) (NYSE:SJR):
Star Choice is excited to announce the launch of The Fight Network(TM) starting February 1, 2006. Star Choice customers will enjoy a free preview of the service until March 31, 2006.
Available on channel 404, The Fight Network is the first and only all combatant sports and entertainment channel that delivers the very best in boxing, wrestling, mixed martial arts, and other combatant styles along with top-notch "fight theme" movies, documentaries, and news 24 hours a day. Pride FC, K-1, TNA Wrestling(Xplosion), Ring of Honor, Showtime Boxing: Shobox, and TKO are just a few of the network's programming highlights.
"We've landed a knock-out punch with the addition of The Fight Network to our channel line-up," said Jim Cummins, Vice-President of National Operations for Star Choice Communications. "Star Choice has more than 420 channels, and over the last year we have added over 20 services, including The Fight Network. With award-winning customer service, and 14 High Definition channels, Star Choice continues to provide the best digital satellite television experience in the country."
"We're thrilled to provide Star Choice customers with non-stop action from all corners of the fight world. This is truly unique programming which we believe will further build-out Star Choice's strong sports line-up with even more viewing options," said Mike Garrow, President of The Fight Network. "We're going the distance with the support of Star Choice and we're confident this network will be a true fan-favourite."
For a complete list of programming and the latest news from the fight world, please visit www.thefightnetwork.com.
About Star Choice Communications Inc
Star Choice Communications Inc., a subsidiary of Shaw Communications Inc. (TSX-SJR.NV.B, NYSE-SJR), is a leading Canadian provider of crystal-clear digital picture and Dolby surround sound audio and video Direct-to-Home (DTH) satellite services. Star Choice delivers one of Canada's largest channel selections to more than 855,000 customers and was recently awarded the top 2005 prize for customer satisfaction, for customer contact in a call centre, within the Telecommunications and TV industry by SQM Group Inc. Star Choice also launched Canada's first elliptical dish, which facilitates multiple satellite reception. Canadians can purchase Star Choice equipment at more than 3,000 locations across the country, including The Source by Circuit City, Best Buy, Future Shop, Leon's and The Brick. Additional information about Star Choice Communications can be found on the Web at www.starchoice.com.
About THE FIGHT NETWORK
The Fight Network is a cross-platform media company with brand interest in television, radio and web. All three of these media offerings are seamlessly integrated to offer fans of combatant sports and related entertainment a true convergence experience. The Fight Network Inc. corporate headquarters is located in Toronto, Canada. Additional information on the company can be found at www.thefightnetwork.com.
Shaw Communications Inc. (TSX:SJR.NV.B) (NYSE:SJR)
O Yeah Good Mourning All
BKMP NEWS Star Choice Brings a Heavyweight Champion to its Channel Line-Up with the Addition of THE FIGHT NETWORK
Business Wire - February 01, 2006 08:00
CALGARY, Alberta, Feb 01, 2006 (BUSINESS WIRE) -- Shaw Communications Inc. (TSX:SJR.NV.B) (NYSE:SJR):
Star Choice is excited to announce the launch of The Fight Network(TM) starting February 1, 2006. Star Choice customers will enjoy a free preview of the service until March 31, 2006.
Available on channel 404, The Fight Network is the first and only all combatant sports and entertainment channel that delivers the very best in boxing, wrestling, mixed martial arts, and other combatant styles along with top-notch "fight theme" movies, documentaries, and news 24 hours a day. Pride FC, K-1, TNA Wrestling(Xplosion), Ring of Honor, Showtime Boxing: Shobox, and TKO are just a few of the network's programming highlights.
"We've landed a knock-out punch with the addition of The Fight Network to our channel line-up," said Jim Cummins, Vice-President of National Operations for Star Choice Communications. "Star Choice has more than 420 channels, and over the last year we have added over 20 services, including The Fight Network. With award-winning customer service, and 14 High Definition channels, Star Choice continues to provide the best digital satellite television experience in the country."
"We're thrilled to provide Star Choice customers with non-stop action from all corners of the fight world. This is truly unique programming which we believe will further build-out Star Choice's strong sports line-up with even more viewing options," said Mike Garrow, President of The Fight Network. "We're going the distance with the support of Star Choice and we're confident this network will be a true fan-favourite."
For a complete list of programming and the latest news from the fight world, please visit www.thefightnetwork.com.
About Star Choice Communications Inc
Star Choice Communications Inc., a subsidiary of Shaw Communications Inc. (TSX-SJR.NV.B, NYSE-SJR), is a leading Canadian provider of crystal-clear digital picture and Dolby surround sound audio and video Direct-to-Home (DTH) satellite services. Star Choice delivers one of Canada's largest channel selections to more than 855,000 customers and was recently awarded the top 2005 prize for customer satisfaction, for customer contact in a call centre, within the Telecommunications and TV industry by SQM Group Inc. Star Choice also launched Canada's first elliptical dish, which facilitates multiple satellite reception. Canadians can purchase Star Choice equipment at more than 3,000 locations across the country, including The Source by Circuit City, Best Buy, Future Shop, Leon's and The Brick. Additional information about Star Choice Communications can be found on the Web at www.starchoice.com.
About THE FIGHT NETWORK
The Fight Network is a cross-platform media company with brand interest in television, radio and web. All three of these media offerings are seamlessly integrated to offer fans of combatant sports and related entertainment a true convergence experience. The Fight Network Inc. corporate headquarters is located in Toronto, Canada. Additional information on the company can be found at www.thefightnetwork.com.
Shaw Communications Inc. (TSX:SJR.NV.B) (NYSE:SJR)
GBIW up 46%, news this mourning
Watching DOR, ALT, EASY.. TPPH had a nice run Yesterday..
GOOD Mourning Stockz, late nite DD I see, gotta turn that computer off sometime Ya no.. LOL
IGTG News
Ingen Technologies, Inc. Pacific Rim Prepares for Oxyview & Oxyalert
PR Newswire - January 31, 2006 07:15
- $15M Asian Market for OxyView & OxyAlert -
CALIMESA, Calif., Jan 31, 2006 /PRNewswire-FirstCall via COMTEX/ -- Ingen Technologies, Inc. (OTC: IGTG), a medical device manufacturer of OxyAlert(TM), OxyView(TM), and Secure Balance(TM), announces that the company has received a proposal from the Tokibo Group to represent the OxyView(TM), OxyAlert(TM) and Secure Balance(TM) in Asia.
The Tokibo Group is a conglomerate of seven companies. Two of the companies, TKB International, Inc. and Newport Medical Instruments, Inc. are located in Costa Mesa, California. Tokibo is the largest independent medical device distributor in Japan and the partner of many prominent US companies such as Cardinal Health, Welch Allyn, Vital Signs and Newport Medical Instruments. Tokibo Co. Hong Kong Ltd is the distributor in Hong Kong and mainland China for many of the same companies.
Due to its strong franchises in the hospital and home care segments, Tokibo is the market leader in the respiratory area in Japan, Hong Kong and China. "We believe that there would be a great deal of synergy between our existing product portfolio and Ingen's products; and that our installed base of customers would enable us to ramp up sales quickly and steadily." Said Elizabeth Sanborn, Vice President of Business Development for TKB International, Inc.
"With the increase in share price, revenues and profits, and as we continue to complete all of the necessary SEC filings to move to the OTCBB; I look forward to establishing OxyView(TM) revenues to strengthen our capital structure and build earnings and value for our shareholders and their investment in IGTG." Said Scott Sand, Chairman and CEO of Ingen Technologies.
About Ingen Technologies, Inc.
BPUR NEWS & Good Mourning
Biopure Begins Selling Hemopure(R) in South Africa
By PR Newswire
Last Update: 1/30/2006 7:00:39 AM Data provided by
CAMBRIDGE, Mass., Jan 30, 2006 /PRNewswire-FirstCall via COMTEX/ -- Biopure Corporation (BPUR) announced today that it has made the first sale of its room-temperature-stable oxygen therapeutic Hemopure(R) (hemoglobin glutamer -- 250 (bovine)) in South Africa. The product is approved in South Africa for the treatment of adult surgical patients who are acutely anemic and for the purpose of eliminating, delaying or reducing the need for allogenic red blood cell transfusions in these patients.*
"This first ever commercial sale of a hemoglobin-based oxygen therapeutic for human use is a milestone in the field of oxygen therapeutics and represents decades of research and development by the company," said Biopure Chairman and CEO Zafiris G. Zafirelis. "It is also an important step in understanding how doctors perceive and use the product outside of clinical trials."
Biopure's initial sales targets are medical providers that have used or been trained to use Hemopure as part of a post-approval medical education program. In April 2001, South Africa's Medicines Control Council granted marketing clearance for the product; however, issues between Biopure and the original product registration holder and distributor delayed marketing and sales activities. In 2005, Biopure acquired control of the product registration, selected a warehousing and shipping agent and appointed a sales agent. In early January 2006, Biopure announced that it had complied with new import regulations and shipped product to South Africa to support the initiation of sales and marketing activities.
About Biopure Corporation
Biopure Corporation develops, manufactures and markets pharmaceuticals, called oxygen therapeutics, that are intravenously administered to deliver oxygen to the body's tissues. Hemopure(R) (hemoglobin glutamer -- 250 (bovine)), or HBOC-201, is approved for sale in South Africa for the treatment of surgical patients who are acutely anemic. The product has not been approved for sale in other jurisdictions, including the U.S. or the European Union. Biopure plans to apply in Europe, in mid 2006, for approval of an acute anemia indication in orthopedic surgery patients. The company's veterinary product Oxyglobin(R) (hemoglobin glutamer -- 200 (bovine)), or HBOC-301, the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission, is indicated for the treatment of anemia in dogs. To date, Biopure has sold approximately 173,000 units of Oxyglobin, which have been used to treat an estimated 90,000 animals.
Thanks Stockz
TPPH what do You think
Who's everybody trading with, I've got Ameritrade, 10.99$ pr trade. I've seen some other co's with as low as 2.99$ but are they reliable
Chris
SONT up 56% Fri, any opinions
AVII news if anyone,s watching & Good Mourning
AVI BioPharma Announces Hepatitis C Virus License Agreement with Chiron
Business Wire - January 27, 2006 09:00
PORTLAND, Ore., Jan 27, 2006 (BUSINESS WIRE) -- AVI BioPharma, Inc. (Nasdaq:AVII), today announced that it has entered into an agreement with Chiron Corp. granting AVI a nonexclusive license to Chiron's patents and patent applications for the research, development and commercialization of antisense therapeutics against hepatitis C virus (HCV). Chiron scientists were the first to clone HCV, and the company has been granted more than 100 HCV-related patents.
The license further strengthens AVI's patent position on its HCV antisense product candidates, which are already covered by issued U.S. patent claims. AVI's lead NEUGENE(R) antisense compound for HCV, AVI-4065, is currently being evaluated in a multicenter exploratory safety and efficacy clinical trial in the U.S. In conjunction with the license agreement, AVI will issue Chiron shares of AVI common stock as an initial license fee payment. Other financial terms of the agreement were not disclosed.
"This agreement with Chiron positions AVI to move forward in our HCV development program with confidence and clarity around intellectual property," said Denis R. Burger, Ph.D., chief executive officer of AVI. "The addition of the HCV patents licensed from Chiron to AVI's own patents provides a solid proprietary base in the HCV field for AVI and our eventual commercial partners."
The multicenter clinical study currently underway is designed to assess the safety, tolerability, pharmacokinetics and viral response to daily subcutaneous administration of AVI-4065 among healthy volunteers and patients with chronic active HCV. AVI recently reported completion of the first phase of this study with favorable safety, tolerability and pharmacokinetic profiles and is now in the second efficacy phase of the program. Additional data are expected from this trial later in the first quarter.
The principal investigator of the clinical trial is Mark Holodniy, M.D., F.A.C.P., professor of medicine at Stanford University School of Medicine and director of the Department of Veterans Affairs Public Health Research & Consultation Program.
More UPDA News
UPDA - Utah Subsidiary West Oil & Gas, Inc. Establishes Offices - Readies to Commence Operations - Masaood Group Commits Additional Funding
By BusinessWire
Last Update: 1/27/2006 6:29:01 AM Data provided by
SALT LAKE CITY, Jan 27, 2006 (BUSINESS WIRE) -- With its Canyon Creek Oil & Gas, Inc. subsidiary continuing to turn additional wells to production in Texas, Universal Property Development and Acquisition Corporation (UPDA) has accelerated its efforts to commence operations in Utah through its West Oil & Gas, Inc. subsidiary. As Canyon Creek has previously reported, it is now generating significant oil and gas production from its wells in both Archer and Palo Pinto Counties, Texas. Further, the substantial natural gas to be produced from its recently completed well in Victoria County, Texas will generate revenues sufficient to fund many future projects.
In preparation for its aggressive expansion, West has established offices in Salt Lake City's landmark Wells Fargo Bank Tower.
West Oil Vice President Rene Kronvold has initiated review of several oil and gas prospects in the Uinta Valley, the Altamont-Bluebell Field and elsewhere in the state of Utah. "We are very anxious to commence operations in Utah," reports Mr. Kronvold. "It has taken some time to get started while UPDA focused on Canyon Creek, but with the remarkable success of UPDA's operations in Texas, the resources now available will allow West to consider opportunities that may otherwise have been out of reach," continued Kronvold.
In order to take advantage of those many opportunities, West will be terminating its relationship with Dark Horse Exploration and Byron T. Woodard. With the expanding involvement of and opportunities being generated by Landmark 4, West is negotiating to undertake projects that are significantly more lucrative than those presented by Dark Horse. In conjunction with this termination, UPDA will increase its stake in West to 70% and Masaood Group, LTD. and Mr. Kronvold will now own 20% of the outstanding shares.
West has determined that its shareholders and the shareholders of UPDA will be best served by pursuing the new drilling and re-work prospects that are being negotiated. The projected production and operating partners are professional, credible and reliable. As a result of its calculation of the potential revenue to result from the projects that West is preparing to undertake, Masaood Group decided to increase its financial commitment to the venture.
"We intend to hit the ground running and expect to overtake Canyon Creek in a very short time," concluded Kronvold. "Within a matter of a very few months, Utah should exceed the contribution of Texas to UPDA's expanding oil and gas production."
More UPDA news
Canyon Creek Successfully Perforates The #1 Roberts Unit
Business Wire - January 26, 2006 15:12
HOUSTON, Jan 26, 2006 (BUSINESS WIRE) -- Canyon Creek Oil & Gas Inc. (A Joint Venture of Universal Property Development and Acquisition Corporation (OTCBB:UPDA) and USProduction & Exploration, LLC (USPX), a privately held Company) successfully removed the residual concrete from the bottom of the #1 Roberts Unit located on its 243 acre lease in Victoria County, Texas this afternoon. Further gamma-ray logs confirmed the excellent quality sand and the neutron log run simultaneously with the gamma-ray indicates gas productive in the Yegua "A", "B" and "C" stringers. Based upon this information, the management of Canyon Creek decided to perforate the well in the lower Yegua "C" sand below 8730'.
Canyon Creek successfully perforated the tubing this afternoon and the well unloaded itself and brought gas to the surface within 30 minutes.
The management of Canyon Creek and UPDA will continue to monitor the well throughout the day.
Upon original completion in 1990, the #1 Roberts Unit flowed at an absolute open flow of 9,000,000 cfg from the Yegua "B" stringer as reported to the Railroad Commission of Texas on Form G-1. The Form G-1 shows the well flowing 2,668 mcfgpd on a 8/64'' choke with 4,727 psi flowing tubing pressure.
HESG news
Health Sciences Group Signs Distribution Agreement for Shugr with DNP International
Business Wire - January 26, 2006 12:00
LOS ANGELES, Jan 26, 2006 (BUSINESS WIRE) -- Health Sciences Group, Inc. (OTCBB:HESG), provider of innovative nutraceutical products and functional food ingredients derived from natural sources, announced today that it has signed a non-exclusive sales and distribution agreement for Shugr with ingredients distributor DNP International, Inc. DNP International is a leading importer and distributor of ingredients to manufacturers in the food, beverage and nutritional supplement industries.
"We are very pleased to continue our relationship with DNP International, who represents some of the best products in the industry," commented Fred E. Tannous, Co-Chairman and CEO of Health Sciences Group. "We believe our partnership with DNP will allow us to not only increase the exposure for Shugr(TM) but also broaden our commercial marketing and sales reach. Through our partnership with DNP, we now have access to the domestic ingredients marketplace and it also moves us closer to our international expansion strategy."
Under the terms of the new agreement, DNP will market and sell Shugr 1X and 10X as raw material ingredient to manufacturers of foods and beverages and nutritional supplement makers throughout the United States and Canada. DNP is subject to a minimum sales requirement targeting $1.0 million in 2006, $4.0 million in 2007 and $5.5 million in 2008.
"DNP is proud to be the ingredients distributor for Shugr(TM), a high-quality, zero-calorie sweetening alternative. Over the past six months we have seen interest in Shugr rise to the top 20 ingredients featured to our customers. Looking ahead, we are expecting high demand for Shugr as more and more of our customers conclude their evaluation and start placing orders in the next few months. We are excited about the future for this alternative zero-calorie sweetener."
Shugr(TM), a zero-calorie, low glycemic sweetener that tastes and measures like table sugar, is made from sugars that occur naturally in such good-tasting, healthy foods such as fruits, vegetables, corn and dairy products. Erythritol is a naturally-occurring sugar commonly found in melon, grapes, mushrooms and soy. Tagatose comes from dairy products, but does not affect people who are lactose intolerant. Tagatose also provides an added health benefit -- prebiotic fiber that promotes intestinal health, much the way yogurt does. Maltodextrin is derived from corn sugar, which is non-GMO and gluten-free. A trace amount of sucralose is added to give Shugr its "high note." All of these ingredients carry a GRAS (Generally Recognized As Safe) designation for food safety from the US Food & Drug Administration.
About DNP International, Inc.
DNP International Co., Inc. imports and distributes raw material ingredients to manufacturers in the food, beverage, dietary supplement, cosmetic and pharmaceutical industries. Founded in 1994, DNP is one of the largest suppliers of raw materials in the United States sourcing over two thousand different ingredients. Headquartered in Whittier, California, DNP has locations in Los Angeles, Chicago and New Jersey. For more information, visit www.dnpint.com.
SRGX news
STRATEGY X, Inc. Discloses Initial Plans to Open Homeland Security Facility
Business Wire - January 26, 2006 10:56
HARRISON, Maine, Jan 26, 2006 (BUSINESS WIRE) -- STRATEGY X, Inc., (PINK SHEETS:SRGX), homeland security specialists, is pleased to announce it has commenced plans for major expansion plans for the company in 2006. The company is planning on opening a Homeland Security Technology Test Facility. This new facility will allow Strategy X, Inc. to Simulate, Research, and Model technology. While the final stand-up plans are still being worked out all of these expansions will take place within the first two quarters of 2006.
Clifford A. Lewis, President and CEO stated, "We've been planning the expansion for several months and we are close to working out the final details. While we are not prepared to discuss specific locations I can discuss our vision for each of these facilities. The modeling & simulation technology training and research development center will focus on the software development that we have already initiated. It will also house a training center geared towards training our effects based process as well as instruction for modeling & simulation. The modeling and simulation laboratory will house a fixed site modeling & simulation center as well as our mobile modeling & simulation teams that will be conducting effects based analysis. Finally, the technology test facility will provide a location for us to test existing as well as emerging technologies. It will also provide a real-world environment for other vendors to have their technology tested by an objective third party."
More than welcome Stockz4O
TERYL news
Teryl Resources Corp. Announces New Gold Targets Located by the 2005 Exploration Activities on the Gil Joint Venture
Business Wire - January 26, 2006 09:00
FAIRBANKS, Alaska, Jan 26, 2006 (BUSINESS WIRE) -- Teryl Resources Corp. (TSX VENTURE:TRC)(Pink Sheets:TRYLF) is pleased to announce an exploration update for the Gil Joint Venture as follows:
Exploration Introduction
The objective of the 2005 Gil Venture exploration program was to generate new gold targets by integrating geologic and geochemical information with newly acquired geophysical data. Work by Fairbanks Gold Mining Inc./Kinross Gold consisted of an update of the geologic database and a high-resolution electromagnetic (HEM) airborne geophysical survey.
The database update began in January and continued intermittently throughout the year. Work focused on revising soil sample locations using updated GPS coordinates, compiling data for geologic map production and revising the resource model. Additional database work is planned for the first quarter of 2006.
In July, Fugro Airborne Surveys Inc., under contract to Fairbanks Gold Mining Inc./Kinross Gold, initiated an HEM airborne geophysical survey of the area. HydroGeophysics Inc. interpreted the geophysical data and identified several targets within the Gil Joint Venture claim block. Additional geophysical analysis is scheduled for 2006.
In July of 2005, Hydrogeophysics Inc. (HGI) delivered an interpretation map with recommendations for geological and geophysical follow-up based on the low resolution geophysical data. Two target areas were identified and recommended for further geologic and geophysical investigation within the Gil Joint Venture area. These targets are as follows:
1) Last Chance Creek
This target occurs on a shear zone approximately 3.1 miles east and 1.2 miles south of the Fort Knox Mine in close proximity to the south end of an interpreted intrusive. The claims in this area are part of the Gil Joint Venture or are held by Fairbanks Gold Mining Inc.
2) Too Much Gold Creek
The Too Much Gold Creek target lies on a shear located on the west edge of an intrusive approximately 6.2 miles east and 1.8 miles north of the Fort Knox Mine. This target is largely located within the Gil Joint Venture, although a portion lies in the Fish Creek Claims. The Fish Creek claims are 50% owned by Linux Gold Corp. and optioned to Teryl Resources Corp., but are not part of the Joint Venture.
The final interpretation was completed on December 16th, 2005 and outlined six areas of interest within or partially within the Gil Joint Venture. Drill holes for three of these target areas were proposed within the Gil Joint Venture.
Gil Joint Venture Recommendations
The goal of the 2006 Gil Joint Venture exploration program should initially focus on completing an overall update of the database. This would include the production of new geologic and geochemical maps. Fieldwork should consist of mapping and sampling across interpreted geophysical and geochemical anomalies. This updated information could then be integrated with the geophysical data to further define existing exploration targets or generate new targets in the Gil Joint Venture claim block.
About Teryl Resources Corp.
With interests in four gold properties, Teryl Resources Corp. is one of the main landowners in the Fairbanks Mining District, Alaska. The Gil project is a joint venture (80% Kinross/20% Teryl) with Kinross Gold Corporation (TSX: K; NYSE: KGC). The Company's holdings also include the Fish Creek Claims, 50% optioned from Linux Gold Corp. (OTC BB: LNXGF), and the Stepovich Claims, where Teryl has a 10% net profit interest from Kinross. The Company also has a 100%-interest in the West Ridge property, and has obtained a mining lease on the adjoining Fox Creek Claims. Teryl Resources Corp. also has one joint venture silver prospect located in Northern BC, Canada. For further information visit the Company's website at http://www.terylresources.com.
VWKM Sells Channel 29 for $1,000,000
Business Wire - January 26, 2006 08:46
VWKM news
ORLANDO, Fla., Jan 26, 2006 (BUSINESS WIRE) -- Vision Works Media Group, Inc. (Pink Sheets:VWKM) announces the sale of Channel 29, which is an asset of a wholly owned subsidiary for $1,000,000 to Orogeny Media LLC.
Orogeny Media LLC will take over programming of Channel 29 to dovetail with the initiation of New Screen TV's programming switch to Satellite AMC 10.
"The sale of Channel 29 creates a huge profit to Vision Works Media Group, Inc. as our interest was a leasehold interest with an option to buy and with national distribution of our programming on Satellite, we do not need to continue with low power local programming," said Mark Astrom, President.
BCLI news
BrainStorm Files Patent Application for Stem Cell Procedure with Potential for Multiple Sclerosis Therapy
Business Wire - January 26, 2006 08:30
NEW YORK & TEL AVIV, Israel, Jan 26, 2006 (BUSINESS WIRE) -- BrainStorm Cell Therapeutics (OTCBB:BCLI), the developer of NurOwn(TM) bone marrow derived stem cell therapeutic products for the treatment of neurodegenerative diseases, announced today that a patent application has been filed with the US Patent and Trademark Office for a new procedure to derive oligodendrocyte-like cells. The invention involves inducing oligodendrocyte-like cells using the company's proprietary bone marrow derived human mesenchymal stem cell technology.
The patent application was filed by the technology transfer company of Tel Aviv University, Ramot, on the basis of research funded by Brainstorm . Worldwide rights to the development and commercialization of the new technology are exclusively licensed to BrainStorm.
"Developing the capability to derive oligodendrocyte-like cells is a major step forward because of the important role that oligodendrocyte cells are believed to have in restoring cell function in patients suffering from Multiple Sclerosis and other demyelinating diseases," said Yoram Drucker, Principal Executive Officer of BrainStorm.
"Now that we have demonstrated that mesenchymal stem cells can be induced to differentiate in vitro to oligodendrocyte lineage and form functional cells, our next goal will be to test the oligodendrocyte-like cells in animal models of Multiple Sclerosis," said Dr. Daniel Offen, BrainStorm's Chief Scientist.
Brainstorm's success in deriving olgodendrocyte-like cells follows several other major technological achievements made by the company during the past year using the company's proprietary bone marrow derived stem cell technology.
In other studies, Brainstorm successfully used bone marrow stem cells to produce dopaminergic-like cells shown to be capable of dopamine secretion and to benefit animal models of Parkinson's disease.
Brainstorm also used its bone marrow stem cell technology to produce astrocyte-like cells with the capacity of producing glial derived neurotrophic factor (GDNF), the most potent neurotrophic factor known for dopaminergic neurons . Transplanted dopamine- and GDNF producing-cells, acting on their own or in combination, hold great promise for replacement and preservation of neurons in Parkinson's and other neurodegenerative diseases.
About BrainStorm Cell Therapeutics Inc.
BrainStorm Cell Therapeutics Inc. is an emerging company developing neural-like stem cell therapeutic products, NurOwn(TM), based on autologous bone marrow derived stromal cells, for treatment of neurodegenerative diseases. NurOwn(TM) patent pending technology is based on discoveries made by the team of prominent neurologist, Prof. Eldad Melamed, Head of Neurology at Rabin Medical Center, and expert cell biologist Dr. Daniel Offen, at the Felsenstein Medical Research Center of Tel-Aviv University, enabling the differentiation of bone marrow derived stem cells into functional neurons and astrocytes, as demonstrated in animal models. The company holds rights to develop and commercialize the technology through an exclusive, worldwide licensing agreement with Ramot at Tel Aviv University Ltd., the technology transfer company of Tel Aviv University. The company's initial focus is on developing treatments for Parkinson's Disease.
IFLB enws
Infinium Labs Receives $5 Million Funding Commitment to Start Phantom Lapboard Manufacturing
PR Newswire - January 26, 2006 08:01
SEATTLE, Jan 26, 2006 /PRNewswire-FirstCall via COMTEX/ -- Infinium Labs, Inc. (OTC Bulletin Board: IFLB), developers of the first end-to-end, on-demand game service for delivery to the living room which allows consumers to try/rent/buy any game, any time from the convenience of their living rooms, announced today that it has received a $5 million funding commitment from Golden Gate Investors in the form of a convertible debenture and warrant.
"This commitment gives the Company a funding path to begin manufacturing the Phantom Lapboard and to launch marketing and sales for the Lapboard which we target for mid-2006, allowing us to start building our manufacturing lines this year, and continue our initiative to launch the Phantom Game Service," noted Greg Koler, Infinium's CEO and President.
The Phantom Lapboard was nominated at the 2004 E3 show alongside Nintendo and Sony for the "BEST OF SHOW" category. It received tremendous response from the 20k-plus attendees that visited Infinium Labs' exhibit as being the first device to allow gamers to comfortably use a mouse and keyboard from their couch. The peripheral rotates for left- and right-handed users and also inclines on a 90-degree angle with a hard surface below for the Phantom Mouse. Consumers have stated that they love the feel of this device; it keeps their hands closer together and provides a better gaming experience. Other applications for this device are geared towards the new digital media centers being developed by companies like Intel and Gateway.
Infinium is currently working with distributors, VAR resellers and e-tailers to start distribution of the Phantom Lapboard, which will be announced in the first half of 2006.
"The Phantom Lapboard and Game Service are attractive investments in new consumer products and services for hedge fund investors," a Golden Gate Investors spokesperson said. "Infinium's new management team has delivered on its short-term goals and we are excited to be involved with the company in taking on the on-line gaming industry."
Under terms of the financing, $625,000 will be funded immediately in three tranches: 1. Closing; 2. Filing of a registration statement; and 3. Effectiveness of the registration statement. That triggers Infinium Labs' ability to exercise up to $5M in convertible debt.
About Infinium Labs
Infinium Labs (OTC Bulletin Board: IFLB) is in development of the Phantom Game Service, anticipated to be the first end-to-end, on-demand game service for delivery to the living room. Delivered over broadband, the Phantom Game Service is designed to offer casual and avid gamers a broad library of titles, available any time, day or night. For more information, please visit http://www.phantom.net.
TGEN news
Targeted Genetics Strengthens Intellectual Property for AAV Vector Manufacturing Purification Processes
Good Mourning and more UPDA NEWS
HOUSTON, Jan 26, 2006 (BUSINESS WIRE) -- Canyon Creek Oil & Gas Inc. (A Joint Venture of Universal Property Development and Acquisition Corporation (OTCBB:UPDA) and USProduction & Exploration, LLC (USPX), a privately held Company) logged 16 feet of Yegua sand at the #1 Roberts Unit located on its 243 acre lease in Victoria County, Texas Tuesday afternoon. A cased-hole gamma-ray log confirms excellent quality sand and the neutron log run simultaneously with the gamma-ray indicates gas productive.
Canyon Creek expects to perforate the well before 10:00 am CST Thursday morning.
While logging the #1 Roberts Unit well, the gamma-ray/neutron tool set down on residual cement in the 2-7/8" tubing at 8700 feet. The Yegua "A" sand was found above 8,700'. Canyon Creek moved in a coiled tubing unit to drill out 30-40' of residual cement in order to access the more prolific Yegua "B" sand.
Donald W. Orr, President of Canyon Creek said, "We are very excited about the quality of the Yegua "A" stringer encountered in the well. When compared with other wells in the area, the Yegua "A" sand appears of higher quality based upon the gamma-ray measurements. The Yegua "B" sand should be even better."
The logging company is currently on location and the coiled tubing unit is working to remove the residual cement from the well. Once the cement is removed, the Company will continue logging operations below 8,700'. Canyon Creek anticipates logging 20' of excellent quality Yegua "B" sand and then perforating both the Yegua "A" and the Yegua "B" pay zones.
Upon original completion in 1990, the #1 Roberts Unit flowed at an absolute open flow of 9,000,000 cfg from the Yegua "B" stringer as reported to the Railroad Commission of Texas on Form G-1. The Form G-1 shows the well flowing 2,668 mcfgpd on a 8/64'' choke with 4,727 psi flowing tubing pressure.
"We intend to produce this well from both the "A" and the "B" zones," continued Orr. "Based on the logs and historical production reports, we are very optimistic of the results."
!! IVAN NEWS
Ivanhoe Energy's California Deep Gas Well Test Disappointing >IVAN
GOOD Mourning ALL
GNBT NEWS
Generex Biotechnology Announces Interim Results Of Clinical Breast Cancer Trials>GNBT
PMU NEWS
Pacific Rim Mining Corp.: High Grade Gold Over Significnt Width Intersected At South Minita >PMU
AVII anyone into this
VWKM NEWS
Vision Works Media Group, Inc. and New Screen TV Announce Satellite Distribution Contract Signing
NEWS UPDA
HOUSTON, Jan 23, 2006 (BUSINESS WIRE) -- Canyon Creek Oil & Gas Inc. (A joint venture of Universal Property Development and Acquisition Corporation (OTCBB:UPDA) and USProduction & Exploration, LLC. (USPX), a privately held Company) has completed its revitalization efforts in the South Markley Field in Young County, Texas and today its #2 Prideaux well will be brought on line.
The #2 Prideaux was completed in February 1982 flowing 300 mcfgpd from the Marble Falls formation at 4,798'. The Marble Falls formation is a prolific oil and gas producer in the state and in the immediate area. It is estimated the reserves remaining total 548,000 mcfg.
Canyon Creek has equipped the #2 Prideaux with a Quincy 270 vacuum pump compressor and the Company is waiting for the gas purchaser to modify its metering system so it can deliver additional gas to the pipeline. Canyon Creek expects the gas production will increase significantly once the Quincy pump is turned on today.
Sunoco will purchase the oil from the #2 Prideaux, and Targa Midstream Services, Ltd., who bought Dynegy Midstream Services, is the named purchaser for the natural gas. Once Targa Midstream modifies its metering site today, Canyon Creek will turn on the Quincy pump to move the casing head gas to the pipeline. The Company will monitor and report daily oil and gas sales to UPDA who provided the funds for the project.
The #2 Prideaux is located in the South Markley Field about 12 miles north of Graham, Texas. With the completion of this project, Canyon Creek now has wells producing in 3 fields with additional wells to be brought on line within days.
Nuvelo Gets FDA Fast Track Status For Alfimeprase>NUVO
SAN CARLOS (Dow Jones)--Nuvelo Inc. (NUVO) received fast-track designation from the Food and Drug Administration for its lead product candidate, alfimeprase, for the treatment of acute peripheral arterial occlusion, or "leg attack."
In a press release Monday, the company said alfimeprase is in Phase 3 clinical trials for the treatment of acute peripheral arterial occlusion and catheter occlusion.
Nuvelo said alfimeprase may also be able to treat strokes, deep venous thrombosis and myocardial infarction.
Acute peripheral arterial occlusion happens when arterial blood flow to a lower limb is blocked by a clot.
Alfimeprase is an enzyme produced by recombinant DNA technology that rapidly resolves blood clots by directly degrading a protein that provides scaffolding for the clots.
Fast-track designation is reserved for new drugs that demonstrate the potential to address an unmet medical need and which are intended for the treatment of a serious or life-threatening condition.
Company Web site: http://www.nuvelo.com
-Josee Rose; Dow Jones Newswires; 201-938-5400; asknewswires@dowjones.com
(END) Dow Jones Newswires
01-23-06 0647ET
Copyright (c) 2006 Dow Jones & Company, Inc.
Copyright © 2006 MarketWatch, Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
News provided by Dow Jones NewswiresSM, PR News Wire™ and Business Wire™. Dow Jones Newswires is a service mark of Dow Jones & Company. PR News Wire is a Trademark of PR Newswire Association, Inc. Business Wire is a registered trademark and service mark of Business Wire.
Ameritrade is not responsible for the quality and suitability of third party financial or investment information or services. Please consult other sources of information and consider your individual financial position and goals before making an investment decision.
Ameritrade, Division of Ameritrade, Inc., member NASD/SIPC. Ameritrade and Ameritrade logos are trademarks or registered trademarks of Ameritrade IP Company, Inc. 2002 Ameritrade IP Company, Inc. All rights reserved. Used with permission.
NEWS ON AVII
Of DOW JONES NEWSWIRES
NEW YORK (Dow Jones)--Shares AVI BioPharma Inc. (AVII) rose over 42% to a new high Friday after three preclinical tests showed its Neugene antisense technology was effective against several flu strains, including avian flu.
In a news release, the Portland, Ore., company said one trial conducted at the Mahidol University in Bangkok confirmed Neugene antisense efficacy against H5N1, or avian flu. Two separate trials showed the drugs efficacy against four other flu strands.
AVI now intends to test the drug's effectiveness in animal studies, as well as file an Investigational New Drug application with the U.S. Food and Drug Administration.
Shares recently rose 42.6%, or $2.52, to $8.41 on volume of 21.7 million compared to average daily volume of 1.5 million.
(MORE TO FOLLOW) Dow Jones Newswires
01-20-06 1121ET
Copyright (c) 2006 Dow Jones & Company, Inc.
Copyright © 2006 MarketWatch, Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
News provided by Dow Jones NewswiresSM, PR News Wire™ and Business Wire™. Dow Jones Newswires is a service mark of Dow Jones & Company. PR News Wire is a Trademark of PR Newswire Association, Inc. Business Wire is a registered trademark and service mark of Business Wire.
Ameritrade is not responsible for the quality and suitability of third party financial or investment information or services. Please consult other sources of information and consider your individual financial position and goals before making an investment decision.
Ameritrade, Division of Ameritrade, Inc., member NASD/SIPC. Ameritrade and Ameritrade logos are trademarks or registered trademarks of Ameritrade IP Company, Inc. 2002 Ameritrade IP Company, Inc. All rights reserved. Used with permission.
They changed the symbol to BWDIE
HIV moving fast
QBID 5.000.000.000 in volume
HSTT up on news
HIV anyone watching
vwkm anyone watching